Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COG

The International Neuroblastoma Pathology Classification (INPC) was the first to clearly define prognostic subgroups in ganglioneuroma (GN) and ganglioneuroblastoma (GNB).

[1]  M. Sakamoto,et al.  Reconstitution of Schwannian stroma in neuroblastomas using human bone marrow stromal cells. , 2008, The American journal of pathology.

[2]  P. Bruzzi,et al.  Retrospective study of childhood ganglioneuroma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  W. Abdullah.  Pediatr Blood Cancer , 2004 .

[4]  D. Stram,et al.  Revision of the International Neuroblastoma Pathology Classification , 2003, Cancer.

[5]  G. Brodeur.  Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.

[6]  Hiroyuki Shimada,et al.  Morphologic features of neuroblastoma (Schwannian stroma‐poor tumors) in clinically favorable and unfavorable groups , 2002, Cancer.

[7]  D. Stram,et al.  Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors , 2001, Cancer.

[8]  W. Gerald,et al.  Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. , 2001, Cancer research.

[9]  K K Matthay,et al.  Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid , 1999 .

[10]  Hiroyuki Shimada,et al.  Terminology and morphologic criteria of neuroblastic tumors , 1999, Cancer.

[11]  K K Matthay,et al.  The International Neuroblastoma Pathology Classification (the Shimada system) , 1999, Cancer.

[12]  D. Stram,et al.  Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Cohn,et al.  Advances in the diagnosis and treatment of neuroblastoma , 1998, Current opinion in oncology.

[14]  G. Tsongalis,et al.  Correlation between Morphologic and Nonmorphologic Prognostic Markers of Neuroblastoma , 1997, Annals of the New York Academy of Sciences.

[15]  P. Ambros,et al.  Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. , 1996, The New England journal of medicine.

[16]  A. Cantor,et al.  Modified histologic grading of neuroblastomas by replacement of mitotic rate with Mitosis Karyorrhexis Index: A clinicopathologic study of 223 cases from the Pediatric Oncology Group , 1996, Cancer.

[17]  F. Berthold,et al.  Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. , 1993, Progress in clinical and biological research.

[18]  A T Look,et al.  Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A. Green,et al.  Clinical manifestations of ganglioneuroma , 1989, Cancer.

[20]  P. Brandtzaeg,et al.  Prognostic factors in Neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis , 1988, Cancer.

[21]  L. Dehner.  Classic Neuroblastoma: Histopathologic Grading as a Prognostic Indicator The Shimada System and Its Progenitors , 1988 .

[22]  H. B. Marsden,et al.  Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. , 1984, Journal of the National Cancer Institute.

[23]  Bove Ke,et al.  Composite ganglioneuroblastoma. An assessment of the significance of histological maturation in neuroblastoma diagnosed beyond infancy. , 1981 .

[24]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[25]  H. B. Marsden,et al.  Histologic patterns of neuroblastoma related to prognosis and clinical staging , 1974, Cancer.

[26]  J. Beckwith,et al.  Observations on the histopathology of neuroblastomas. , 1968, Journal of pediatric surgery.

[27]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[28]  Professor Dr. H. E. Robertson.  Das Ganglioneuroblastom, ein besonderer Typus im System der Neurome , 1915, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.

[29]  D. Stram,et al.  Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  K. Bauer,et al.  Evidence for molecular heterogeneity in human ganglioneuroblastoma. , 1993, Pediatric pathology.

[31]  A. J. Mcadams,et al.  Composite ganglioneuroblastoma. An assessment of the significance of histological maturation in neuroblastoma diagnosed beyond infancy. , 1981, Archives of pathology & laboratory medicine.

[32]  Stout Ap.  Ganglioneuroma of the sympathetic nervous system. , 1947 .

[33]  A. Stout.  Ganglioneuroma of the sympathetic nervous system. , 1947, Surgery, gynecology & obstetrics.